4 free views remaining today
autosomal dominant intellectual developmental disorder 56
Description
Autosomal Dominant Intellectual Developmental Disorder 56 (ADIDD56) is a form of intellectual disability characterized by global developmental delay, intellectual disability, hypotonia, delayed walking, and other associated features.
- Global developmental delay refers to a significant delay in the achievement of motor or mental milestones in children, including motor skills, speech and language, cognitive skills, and social-emotional development [1].
- Intellectual disability is a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior [2][6].
- Hypotonia refers to low muscle tone, which can affect an individual's ability to move and maintain posture.
- Delayed walking is a common feature of ADIDD56, indicating a significant delay in the development of motor skills.
ADIDD56 is a rare genetic neurodevelopmental disorder characterized by global developmental delay (DD) and variable degrees of intellectual disability (ID) [9]. The exact cause of ADIDD56 is not well understood, but it is believed to be related to genetic mutations that affect brain development and function.
Additional Characteristics
- intellectual disability
- hypotonia
- global developmental delay
- delayed walking
Signs and Symptoms
Based on my analysis, I found that there are several search results related to autosomal dominant intellectual developmental disorders, but none specifically mention "autosomal dominant intellectual developmental disorder 56". However, I can provide information on the general signs and symptoms of intellectual developmental disorders.
Intellectual developmental disorders (IDDs) are characterized by significant impairments in cognitive functioning, adaptive behavior, and/or both. The severity and impact of IDDs can vary widely among individuals.
Some common signs and symptoms of IDDs include:
- Developmental delays: Delays in achieving milestones such as sitting, standing, walking, and talking [1].
- Intellectual disability: Significant impairments in cognitive functioning, including difficulties with learning, problem-solving, and memory [2].
- Adaptive behavior deficits: Challenges with everyday activities, such as personal care, communication, and social interactions [3].
- Speech and language difficulties: Delays or difficulties with speech development, articulation, and comprehension [4].
It's essential to note that each individual with an IDD may exhibit a unique combination of symptoms. If you're looking for information on autosomal dominant intellectual developmental disorder 56 specifically, I couldn't find any relevant information in the search results provided.
However, if you'd like me to search again or provide more general information on IDDs, please let me know!
References:
[1] Context result 2 [2] Context result 3 [3] Context result 4 [4] Context result 6
Additional Symptoms
- Intellectual disability
- Developmental delays
- Speech and language difficulties
- Adaptive behavior deficits
Diagnostic Tests
Autosomal dominant intellectual developmental disorder (ID) 56, also known as intellectual disability ID 56, is a genetic condition characterized by significantly below-average general intellectual functioning associated with impairments in adaptive behavior.
Available Diagnostic Tests:
- Clinical tests: There are 16 clinical tests available for this condition [2].
- Molecular Genetics Tests:
- Deletion/duplication analysis (12 tests available) [2]
- Diagnostic exome sequencing (involves analysis of exome sequencing data in a predefined set of genes associated with non-syndromic ID) [10]
Other Relevant Information:
- Prenatal diagnosis is possible where the pathogenic variant has previously been identified in a family member [6].
- Genetic testing can be used to confirm the diagnosis and identify the underlying genetic cause [5].
References:
[1] Not available (no relevant information found)
[2] Available tests for autosomal dominant ID 56, including clinical tests and molecular genetics tests.
[3] Not available (no relevant information found)
[4] Intellectual developmental disorder, autosomal dominant 23 is characterized by below-average intellectual functioning and impairments in adaptive behavior [4].
[5] Pivalizza PP. Genetic testing for intellectual disability: a review of the literature. [5]
[6] Prenatal diagnosis is possible where the pathogenic variant has previously been identified in a family member.
[7] A disorder characterized by significantly below-average general intellectual functioning associated with impairments in adaptive behavior.
[8] Not available (no relevant information found)
[9] Parsamanesh N. Vital parameters for detecting intellectual disability: a systematic review. [9]
[10] The intellectual disability exome involves analysis of exome sequencing data in a predefined yet regularly updated set of genes associated with non-syndromic ID.
Note: The references are based on the search results provided and may not be an exhaustive list of all relevant information available on this topic.
Additional Diagnostic Tests
- duplication analysis
- Clinical tests
- Diagnostic exome sequencing
Treatment
Based on the search results, it appears that there are limited resources available for specific information on drug treatment for Autosomal Dominant Intellectual Developmental Disorder (ADIDD) 56.
However, I can provide some general information on the topic. According to search result [4], Risperidone is a well-documented treatment of disruptive, aggressive, and self-injurious behaviors in children with intellectual development disorder, which may be relevant to ADIDD 56.
Additionally, search result [5] provides integrated disease information for Intellectual Developmental Disorder, Autosomal Dominant 5 (IDAD5), but it does not specifically mention drug treatment for IDAD56. However, it is possible that some of the treatments mentioned for IDAD5 may be applicable to ADIDD 56.
It's also worth noting that search result [7] provides a comprehensive review on the diagnosis and therapy of intellectual disability (ID), which includes information on various treatment options, but again, it does not specifically mention drug treatment for ADIDD 56.
Unfortunately, I couldn't find any specific information on drug treatment for ADIDD 56. If you're looking for more detailed information, I would recommend consulting a medical professional or searching for peer-reviewed articles on the topic.
References: [4] - Risperidone is a well-documented treatment of disruptive, aggressive, and self-injurious behaviors in children with intellectual development disorder with good ... [5] - Integrated disease information for Intellectual Developmental Disorder, Autosomal Dominant 5 including associated genes, mutations, phenotypes, pathways, ... [7] - by K Hou ยท 2024 โ In this review, the physiological basis of gene variations in ID is systematically explained, the diagnosis and therapy of ID is comprehensively described.
Recommended Medications
๐ Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
The differential diagnosis for autosomal dominant intellectual developmental disorder (MRD6) includes a wide range of conditions that can present with similar symptoms.
- Other autosomal dominant disorders, such as achondroplasia, some forms of amelogenesis imperfecta, and Marfan syndrome, should be considered in the differential diagnosis [3].
- The syndrome has an extensive differential diagnosis, including all other syndromes associated with neurodevelopmental disorder, seizure, obesity, and behavioral disturbances [4].
- Conditions such as Crouzon syndrome with acanthosis nigricans (Crouzonodermoskeletal syndrome), Cohen syndrome, and intellectual disability due to hypogenitalism should also be ruled out [8][9].
It's essential to consider these conditions in the differential diagnosis of MRD6 to ensure accurate diagnosis and treatment. A comprehensive evaluation by a qualified healthcare professional is necessary to determine the underlying cause of the symptoms.
References: [3] Other autosomal dominant disorders include achondroplasia, some forms of amelogenesis imperfecta, and Marfan syndrome. [4] The differential diagnosis includes all other syndromes associated with neurodevelopmental disorder, seizure, obesity and behavioral disturbances. [8] intellectual disability, hypogenitalism. Inheritance is autosomal recessive. Crouzon syndrome with acanthosis nigricans (Crouzonodermoskeletal ... [9] Cohen syndrome is a rare genetic disorder marked by multi-systemic involvement, causing developmental delays, intellectual disabilities,microcephaly and ...
Additional Differential Diagnoses
- Other autosomal dominant disorders
- All other syndromes associated with neurodevelopmental disorder, seizure, obesity and behavioral disturbances
- Crouzon syndrome with acanthosis nigricans (Crouzonodermoskeletal syndrome)
- intellectual disability
- Cohen syndrome
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0080226
- core#notation
- DOID:0080226
- oboInOwl#hasDbXref
- MIM:617854
- rdf-schema#label
- autosomal dominant intellectual developmental disorder 56
- oboInOwl#hasExactSynonym
- autosomal dominant mental retardation 56
- IAO_0000115
- An autosomal dominant intellectual developmental disorder that is characterized by global developmental delay, intellectual disability and in most cases hypotonia, delayed walking, poor fine motor skills, and poor or absent speech that has_material_basis_in heterozygous mutation in the CLTC gene on chromosome 17q23.
- rdf-schema#subClassOf
- t353613
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_2596
- owl#annotatedSource
- t353610
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.